SLC22A2 and type 2 diabetes mellitus: SLC22A2 has been implicated in the regulation of plasma lactate levels, particularly in the context of CVD and T2DM, with TT-carriers of the SLCA22A2-rs316019 variant showing significantly higher fasting plasma lactate concentrations (Li et al., 2010).